 |
|
Effects of aristolochic acid I and/or hypokalemia on tubular damage in C57BL/6 rat with aristolochic acid nephropathy
Joo-Hark Yi, Sang-Woong Han, Wan-Young Kim, Jin Kim, Moon-Hyang Park
Korean J Intern Med. 2018;33(4):763-773. Published online 2017 Feb 15 DOI: https://doi.org/10.3904/kjim.2016.097
|
|
Citations to this article as recorded by
 Evaluation and management of hypernatremia in adults: clinical perspectives
Giae Yun, Seon Ha Baek, Sejoong Kim
The Korean Journal of Internal Medicine.2023; 38(3): 290. CrossRef Nephrotoxicity of Herbal Medicine and Its Prevention
Xiaofen Xu, Ruyi Zhu, Jialiang Ying, Mengting Zhao, Xin Wu, Gang Cao, Kuilong Wang
Frontiers in Pharmacology.2020;[Epub] CrossRef Aristolochic acid I aggravates renal injury by activating the C3a/C3aR complement system
Jing Ye, Zhizhi Qian, Mei Xue, Yamin Liu, Sirui Zhu, Yu Li, Xiaoli Liu, Danhong Cai, Jia Rui, Liang Zhang
Toxicology Letters.2019; 312: 118. CrossRef Systematic Overview of Aristolochic Acids: Nephrotoxicity, Carcinogenicity, and Underlying Mechanisms
Jiayin Han, Zhong Xian, Yushi Zhang, Jing Liu, Aihua Liang
Frontiers in Pharmacology.2019;[Epub] CrossRef
|